U.S. Pharmacist Weekly News

March 14, 2018

Higher Steroids Don’t Prevent Asthma Flare-Ups in Mild/Moderate Pediatric Cases
Increasing the dose of inhaled steroids in children with mild/moderate asthma doesn’t have the desired effect and could have unintended consequences, according to a new study. Here’s why pharmacists might want to raise a red flag with with too-frequent refills.

Rare Serotonin Syndrome Shouldn’t Prohibit Depression, Migraine Treatment
More than a decade ago, the FDA cautioned about the concurrent use of drugs for depression and migraines. Now, a new study questions the guidance, noting that serotonin syndrome—the potential risk—is very rare. Here are the details.

Metformin Use During Pregnancy Might Increase Offspring Weight Issues
Metformin prescriptions for pregnant women are on the increase, with growing diagnoses of polycystic ovary syndrome and gestational diabetes. The concern, however, is that the commonly prescribed drug can increase the risk of being overweight or obese for the offspring, a new study suggests. Here is more information for pharmacists.

Small Study Reports Troubling Abuse Potential for Gabapentin
Gabapentin is recommended as an alternative to avoid overuse of opioids for pain control. A new study suggests, however, that the drug is also being misused. Find out how researchers came to that conclusion.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App